| Revenues | | 17,415.00 | 19,133.00 | 17,638.00 | 16,569.00 |
| Cost Of Revenue | | 11,306.00 | 13,307.00 | 11,673.00 | 10,807.00 |
| | 1,816.00 | - | - | - |
| Selling, General, and Administrative | | 1,816.00 | - | - | - |
| Research and Development | | 537.00 | - | - | - |
| Costs And Expenses | | 14,330.00 | 16,473.00 | 14,586.00 | 13,709.00 |
| Operating Income/Loss | | 3,085.00 | 2,660.00 | 3,052.00 | 2,860.00 |
| Income/Loss From Equity Method Investments | | 7.00 | 87.00 | 8.00 | 7.00 |
| Income/Loss From Continuing Operations Before Tax | | 3,211.00 | 3,026.00 | 3,127.00 | 2,818.00 |
| Income Tax Expense/Benefit, Deferred | | 534.00 | 165.00 | 410.00 | -72.00 |
| Income Tax Expense/Benefit | | 670.00 | 712.00 | 836.00 | 646.00 |
| | 2,548.00 | 2,401.00 | 2,299.00 | 2,179.00 |
| Available To Common Stockholders, Basic | | 2,549.00 | 2,402.00 | 2,300.00 | 2,179.00 |
| Attributable To Noncontrolling Interest | | -1.00 | -1.00 | -1.00 | - |
| Basic Average Shares | | 463.40 | -1.30 | 468.60 | 469.70 |
| Diluted Average Shares | | 465.80 | -1.10 | 470.80 | 471.50 |
| Basic Earnings Per Share | | 5.50 | 5.14 | 4.91 | 4.64 |
| Diluted Earnings Per Share | | 5.47 | 5.12 | 4.88 | 4.62 |
| Common Stock Dividends | 3.14 | - | 3.02 | - | 2.92 |
CAT
